Source: PR Newswire

Press Release: Ivantis : Ivantis Recognized For Innovation, Excellence And Company Culture

IRVINE, Calif., Dec. 16, 2020 /PRNewswire/ -- Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure in patients with open-angle glaucoma, is proud to be the recipient of multiple awards and recognition...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Dave Van Meter's photo - President & CEO of Ivantis

President & CEO

Dave Van Meter

CEO Approval Rating

86/100

Read more